Search This Blog

Tuesday, May 5, 2020

Supernus Pharmaceuticals EPS beats by $0.13, beats on revenue

Supernus Pharmaceuticals (NASDAQ:SUPN): Q1 GAAP EPS of $0.40 beats by $0.13.
Revenue of $94.97M (+11.1% Y/Y) beats by $10.96M.
Shares +22.7% AH.
Press Release
https://seekingalpha.com/news/3569738-supernus-pharmaceuticals-eps-beats-0_13-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)